News

INSPIRING HOPE FOR PRETERM BABIES AT RISK OF NECROTISING ENTEROCOLITIS

181214_Harvard_FLRF.jpg

When scientists discovered breastmilk plus a probiotic might ward off the inflammation responsible for necrotising enterocolitis – a devastating disease that affects 10% of preterm infants – they quickly launched a follow-on study to learn more.

These scientists have now found that the combination not only has anti-inflammatory effects, but also anti-viral effects and the potential to regulate healthy growth and development of immature intestinal cells. This further reinforces the possibility that breastmilk plus a probiotic could prevent and potentially treat NEC.

Their findings have just been published by Scientific Reports in this open access article, ‘The impact of indole-3-lactic acid on immature intestinal innate immunity and development: a transcriptomic analysis’.

The Family Larsson-Rosenquist Foundation is a grateful, partial sponsor of this work by the Mucosal Immunology and Biology Research Center, Massachusetts General Hospital for Children, Harvard Medical School, the Institute of Agro-Product Processing, Jiangsu Academy of Agricultural Sciences and the Department of Pediatrics, Kangnam Sacred Heart Hospital, Hallym University College of Medicine.

Please sign up for our newsletter to keep current on this and related news.